DOI: https://doi.org/None

E.V. Blynskaya (1), PhD; S.V. Tishkov (1); Professor K.V. Alekseev (2), PhD; A.I. Marakhova (3), PhD 1-V.V. Zakusov Research Institute of Pharmacology; 8, Baltiyskaya St., Moscow 125315, Russian Federation; 2-Moscow Medical University REAVIZ; 2, Krasnobogatyrskaya St., Build. 2, Moscow 107564, Russian Federation; 3-Peoples’ Friendship University of Russia; 6, Miklukho-Maklai St., Moscow 117198, Russian Federation

Lyophilization of protein and peptide drugs is a promising method for designing stable and effective parenteral dosage forms. The paper considers the basic excipients used in the lyophilization of protein and peptide drugs, as well as their functional classification. It gives the characteristics of vehicles, cryoprotectants, lyoprotectants, tonicity modifiers, surfactants, and buffer systems. It also provides recommendations to solve the problems of preservation of the activity of a drug. The optimal combinations of excipients are proposed to improve the properties of lyophilisate tablets and to prevent their destruction.

protein and peptide drugs

  1. Tang X.C., Pikal M.J. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharmaceutical research., 2004; 21(2): 191–200.
  2. Chang B.S., Patro S.Y. Freeze-drying process development for protein pharmaceuticals. Lyophilization of biopharmaceuticals. American Association of Pharmaceutical Scientists. Arlington, 2004; 113–8.
  3. Banga A.K. Therapeutic peptides and proteins: Formulation, processing, and delivery systems. CRC press, 2015.
  4. Overcashier D.E., Patapoff T.W., Hsu C.C. Lyophilization of protein formulations in vials: Investigation of the relationship between resistance to vapor flow during primary drying and small-scale product collapse. Journal of pharmaceutical sciences, 1999; 88 (7): 688–95.
  5. Liu J. Physical characterization of pharmaceutical formulations in frozen and freeze-dried solid states: techniques and applications in freeze-drying development. Pharmaceutical development and technology, 2006; 11 (1): 3–28.
  6. Chi E.Y. Excipients and their Effects on the Quality of Biologics. VA, USA: American Association of Pharmaceutical Scientists. FDD Tech Corner, 2012.
  7. Carpenter J.F. et al. Rational design of stable lyophilized protein formulations: theory and practice. Rational design of stable protein formulations. Springer US, 2002: 109–33.
  8. Chang L.L. et al. Mechanism of protein stabilization by sugars during freeze-drying and storage: Native structure preservation, specific interaction, and/or immobilization in a glassy matrix? Journal of pharmaceutical sciences, 2005; 94 (7): 1427–44.
  9. Hottot A., Vessot S., Andrieu J. Freeze drying of pharmaceuticals in vials: Influence of freezing protocol and sample configuration on ice morphology and freeze-dried cake texture. Chemical Engineering and Processing: Process Intensification, 2007; 46 (7): 666–74.
  10. Searles J.A., Carpenter J.F., Randolph T.W. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine Tg’ in pharmaceutical lyophilization. Journal of pharmaceutical sciences, 2001; 90 (7): 872–87.
  11. Rey L. (ed.). Freeze-drying/lyophilization of pharmaceutical and biological products. CRC Press, 2016.
  12. Sarciaux J.M. et al. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying. Journal of pharmaceutical sciences, 1999; 88 (12): 1354–61.